In the present study, GeCKO screening and cell viability test results revealed that MMP15, MRPL48, CALN1 and HADHB genes might be involved in drug sensitivity to CTX in CRC cell (Caco-2). This evidence concerns the gene MMP15 and colorectal carcinoma.